ELEVATED EXPRESSION OF ICAM1 (CD54) AND MINIMAL EXPRESSION OF LFA3 (CD58) IN EPSTEIN-BARR-VIRUS-POSITIVE NASOPHARYNGEAL CARCINOMA-CELLS

被引:37
作者
BUSSON, P [1 ]
ZHANG, Q [1 ]
GUILLON, JM [1 ]
GREGORY, CD [1 ]
YOUNG, LS [1 ]
CLAUSSE, B [1 ]
LIPINSKI, M [1 ]
RICKINSON, AB [1 ]
TURSZ, T [1 ]
机构
[1] UNIV BIRMINGHAM, SCH MED, DEPT CANC STUDIES, CANC RES CAMPAIGN LABS, BIRMINGHAM B15 2TJ, W MIDLANDS, ENGLAND
关键词
D O I
10.1002/ijc.2910500605
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Undifferentiated nasopharyngeal carcinoma (NPC) is a remarkable entity among human tumors because of its constant association with the Epstein-Barr virus (EBV). Malignant epithelial cells harbor the EBV genome and often express at least 2 species of latent EBV protein (EBNA1 and LMP1). Despite the massive presence of tumor-infiltrating lymphocytes, NPC cells obviously escape immune surveillance directed to EBV antigens. Previous investigations carried out on EBV-positive Burkitt lymphoma (BL) cells have shown that this fact may be partially accounted for by a lack of expression of ICAM1 (CD54) and LFA3 (CD58). ICAM1 and LFA3 have therefore been investigated in fresh NPC biopsies and transplanted NPCs. With only 1 exception out of 9 cases, NPC cells appear to express high levels of ICAM1 and low levels of LFA3. This is a complete inversion of the pattern observed in normal epithelial cells in vivo. Additional investigations will be required to determine to what extent these characteristics affect T-cell interactions with NPC cells, specially in the process of EBV-antigen recognition.
引用
收藏
页码:863 / 867
页数:5
相关论文
共 26 条
[1]   RELATIONSHIP BETWEEN EPSTEIN-BARR VIRUS AND UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - CORRELATED NUCLEIC-ACID HYBRIDIZATION AND HISTOPATHOLOGICAL EXAMINATION [J].
ANDERSSONANVRET, M ;
FORSBY, N ;
KLEIN, G ;
HENLE, W .
INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (04) :486-494
[2]  
BATSAKIS JG, 1979, TUMORS HEAD NECK, P188
[3]   ISOLATION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS USING MONOCLONAL-ANTIBODIES [J].
BEVERLEY, PCL ;
LINCH, D ;
DELIA, D .
NATURE, 1980, 287 (5780) :332-333
[4]   ESTABLISHMENT AND CHARACTERIZATION OF 3 TRANSPLANTABLE EBV-CONTAINING NASOPHARYNGEAL CARCINOMAS [J].
BUSSON, P ;
GANEM, G ;
FLORES, P ;
MUGNERET, F ;
CLAUSSE, B ;
CAILLOU, B ;
BRAHAM, K ;
WAKASUGI, H ;
LIPINSKI, M ;
TURSZ, T .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (04) :599-606
[5]   EPSTEIN-BARR VIRUS-CONTAINING EPITHELIAL-CELLS FROM NASOPHARYNGEAL CARCINOMA PRODUCE INTERLEUKIN 1-ALPHA [J].
BUSSON, P ;
BRAHAM, K ;
GANEM, G ;
THOMAS, F ;
GRAUSZ, D ;
LIPINSKI, M ;
WAKASUGI, H ;
TURSZ, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6262-6266
[6]   TRANSFORMING ACTIVITY OF NASOPHARYNGEAL CARCINOMA DNA DETECTABLE IN MOUSE JB6-CELLS [J].
COLBURN, NH ;
RAABTRAUB, N ;
BECKER, D ;
CAO, Y ;
WINTERSTEIN, D .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (06) :1012-1016
[7]   EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN INHIBITS HUMAN EPITHELIAL-CELL DIFFERENTIATION [J].
DAWSON, CW ;
RICKINSON, AB ;
YOUNG, LS .
NATURE, 1990, 344 (6268) :777-780
[8]  
DUSTIN ML, 1986, J IMMUNOL, V137, P245
[9]   EXPRESSION OF EPSTEIN-BARR VIRUS-ENCODED PROTEINS IN NASOPHARYNGEAL CARCINOMA [J].
FAHRAEUS, R ;
FU, HL ;
ERNBERG, I ;
FINKE, J ;
ROWE, M ;
KLEIN, G ;
FALK, K ;
NILSSON, E ;
YADAV, M ;
BUSSON, P ;
TURSZ, T ;
KALLIN, B .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) :329-338
[10]   CYTOTOXIC POTENTIAL DESPITE IMPAIRED ACTIVATION PATHWAYS IN LYMPHOCYTES-T INFILTRATING NASOPHARYNGEAL CARCINOMA [J].
FERRADINI, L ;
MIESCHER, S ;
STOECK, M ;
BUSSON, P ;
BARRAS, C ;
CERFBENSUSSAN, N ;
LIPINSKI, M ;
VONFLIEDNER, V ;
TURSZ, T .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (03) :362-370